Press Releases

Results found (113)
May 9, 2018
Japan’s Canon Inc.’s First Acquisition in Israel: BriefCam, A Hebrew...

May 9, 2018 – Jerusalem – Today, the Japanese giant, Canon Inc. announced its acquisition of BriefCam, the industry’s leading provider of Video Synopsis® solutions, which is based on technology developed at The Hebrew University of Jerusalem. The...

May 8, 2018
Yissum and AgrInnovation Launch HUGrow, a Food and Ag-Tech Accelerator

May 8, 2018 – Jerusalem – Yissum, The Technology Transfer Company of The Hebrew University of Jerusalem, in collaboration with its seed investment fund AgrInnovation, today announced the launch of HUGrow, a new food and ag-tech accelerator...

May 2, 2018
Tyson Ventures Announces Investment in Future Meat Technologies

JERUSALEM, ISRAEL – Future Meat Technologies has announced a $2.2 million seed investment round co-led by Tyson Ventures, the venture capital arm of Tyson Foods.  Tyson Foods is a Fortune 100 company, and one of the world’s largest food...

February 6, 2018
Merck Expands Jerusalem Hub

Jerusalem, Israel, February 6, 2018 – Merck, a leading science and technology company, today inaugurated a new technology innovation laboratory at its subsidiary Qlight Nanotech in Jerusalem, hosted on the Hebrew University’s Edmund J. Safra...

May 22, 2017
NewStem Introduces Novel Technology for Predicting Resistance to Chemotherapies

NewStem, introduces a novel technology for predicting resistance to chemotherapy treatments. The Company is developing a diagnostic kit based on the pioneering research of Professor Nissim Benvenisty, the Azrieli Center for Stem Cells and Genetic...

April 5, 2017
Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug...

Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...

December 12, 2016
Sun Pharma & Moebius Medical sign exclusive global licensing deal to develop...

Clinical data showed superior efficacy & similar safety of MM-II vs. standard of care (hyaluronic acid) for treatment of pain in osteoarthritis
Sun Pharma to fund further development of MM-II including completion of Phase 2 and Phase 3 clinical...

December 1, 2016
Lyotropic Delivery Systems Introduces Bio-Enhanced CBD Products

Revolutionary new technology gives cannabinoids unparalleled access to bloodstream.
Commercial launch by Ananada Scientific of HYGIA Nutrients Brand took place at the Marijuana Business Conference in Las Vegas.

September 22, 2016
Agrinnovation, Yissum’s Agritech Investment Fund, Invests in Medical...

Yissum Research Development Company of the Hebrew University of Jerusalem, the technology-transfer company of the Hebrew University, announced today that Agrinnovation, an investment fund focused on agricultural inventions, has entered into an...

July 18, 2016
RenewSense Enters Brainnovation, Israel’s Brain Technologies Accelerator

Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that RenewSense was selected to enter Brainnovation, Israel’s Brain Technologies accelerator.
 
RenewSenses, based on...

June 13, 2016
Yissum Licenses Technology for Enhanced Digital Image Processing to Lightricks

Yissum announced that it has signed a non-exclusive worldwide licensing agreement and a consulting agreement with Lightricks for the development and commercialization of an imaging technology that improves digital image processing. The...

May 24, 2016
Yissum to Receive $1.2 million of Funding from Aurum Ventures for...

Non-invasive diagnostic test realizes the potential of circulating DNA for detection of multiple diseases